Details of the Drug

General Information of Drug (ID: DMOIKB3)

• Drug Name: 5-Hydrazino-1H-tetrazole
• Synonyms: 5-Hydrazino-1H-tetrazole; 5-hydrazinyl-1H-tetrazole; FXYYVODGZXUHLT-UHFFFAOYSA-N; 5-hydrazinotetrazole; AC1LA0KS; 2H-tetrazol-5-ylhydrazine; 1H-tetrazol-5-ylhydrazine; SCHEMBL94795; CTK7F1894; ZX-AN011348; ALBB-012551; NSC206227; STL421139; AKOS000295392; ZINC100158257; NSC-206227; 1H-1,2,3,4-Tetrazole, 5-hydrazino-; 1H-tetrazole, 5-hydrazino-, hydrochloride; BB 0259716
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 100.08
  Logarithm of the Partition Coefficient (xlogp); -1
  Rotatable Bond Count (rotbonds); 1
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: CH4N6
  IUPAC Name: 2H-tetrazol-5-ylhydrazine
  Canonical SMILES: C1(=NNN=N1)NN
  InChI: InChI=1S/CH4N6/c2-3-1-4-6-7-5-1/h2H2,(H2,3,4,5,6,7)
  InChIKey: FXYYVODGZXUHLT-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 459489
  CAS Number: 40925-73-3
  TTD ID: D0EC1A

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cystathionine gamma-lyase (CTH)	TTLQUZS	CGL_HUMAN	Inhibitor	[1]

References

• [1] Cystathionine--lyase (CSE) inhibitors. US9725426.